0 Commenti
0 condivisioni
180 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Arthritis Market Revenue Forecast, Future Scope, Challenges, Growth Drivers"Future of Executive Summary Arthritis Market: Size and Share Dynamics Data Bridge Market Research analyses that the global arthritis market, which was USD 4.3 billion in 2022, would rocket up to USD 8.63 billion by 2030 and is expected to undergo a CAGR of 9.10% during the forecast period. The Arthritis Market report offers an analytical assessment of the prime challenges faced by the...0 Commenti 0 condivisioni 212 Views 0 Anteprima
-
Global Rheumatology Therapeutics Market Witnessing Steady Growth Amid Increasing Arthritis CasesThe global rheumatology therapeutics market was valued at USD 48.8 Bn in 2023 and is expected to grow steadily over the forecast period. The market is estimated to expand at a CAGR of 2.6% from 2024 to 2034, driven by the rising prevalence of autoimmune and inflammatory diseases such as rheumatoid arthritis, increasing awareness about early diagnosis, and ongoing advancements in biologic and...0 Commenti 0 condivisioni 91 Views 0 Anteprima
-
Rheumatoid Arthritis Treatment Market: Industry Analysis and ForecastIntroduction Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation, pain, and progressive joint damage. It affects millions of people worldwide, significantly impairing their quality of life and productivity. The management of RA requires a combination of pharmacological interventions, lifestyle modifications, and patient-centric care. As awareness about early...0 Commenti 0 condivisioni 181 Views 0 Anteprima
-
Rising Demand for Orthopedic Drugs Drives Market Growth at 4.7% CAGR Through 2034According to a new report from Intel Market Research, the global prescription orthopedic drugs market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034, growing at a steady CAGR of 4.7% during the forecast period (2026–2034). This sustained growth reflects an aging global population's increasing need for musculoskeletal treatments and continuous...0 Commenti 0 condivisioni 126 Views 0 Anteprima
-
The Maturing Segment: Assessing TNF-α Antagonists Product Types, Patent Expiries, and the Market Trend toward Biosimilar AdoptionThe Tumor Necrosis Factor-alpha (TNF-α) Antagonists represent the most established and largest segment within the biological product types used for Rheumatoid Arthritis. Having revolutionized treatment decades ago, these injectable therapies have a wealth of clinical data supporting their efficacy and long-term use cases in moderate-to-severe disease. However, this segment is now reaching...0 Commenti 0 condivisioni 351 Views 0 Anteprima